Register entry
Barbara Ann Karmanos Cancer Hospital
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FLUDEOXYGLUCOSE F-18 | FLUDEOXYGLUCOSE F-18 | injection, intravenous | 78714-001ANDA |
Compare
Other companies listing fludeoxyglucose f-18
- BRIGHAM AND WOMEN`S HOSPITAL, INC., THE1 site · 2 NDC
- UIHC-PET Imaging Center1 site · 2 NDC
- Precision Nuclear, LLC0 sites · 3 NDC
Enquiry
Common questions
- Is Barbara Ann Karmanos Cancer Hospital FDA approved?
- Barbara Ann Karmanos Cancer Hospital holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Barbara Ann Karmanos Cancer Hospital make?
- 1 product is listed under Barbara Ann Karmanos Cancer Hospital in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.